CVS Health's Coram discontinues infusion services for antibiotics, inotropic meds, and more, plans to close or sell 29 regional pharmacies.

The annual enrollment period for Medicare Advantage plans and Medicare Part D prescription drug plans starts Tuesday and runs ...

Shares of CVS Health (NYSE:CVS) traded marginally lower on Friday after rising from a low of $62.92 from past six trading sessions, where shares grew overall 6% to a high of $66.63. Today’s the stock ...

Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...

Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

Aetna®, a CVS Health® company (NYSE: CVS), announced the State of Michigan has recommended the company for a new contract to ...

Medicare Advantage plans are changing their quality ratings, with the Centers for Medicare & Medicaid Services (CMS) ...

About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.

PBMs are under the microscope for allegedly inflating drug prices. New Barron’s reporting raises broader questions about the ...

The prior authorization process for patients with cancer demonstrates fewer days until submission and lower denial rates for Asian patients relative to White patients.

Teva Pharmaceutical Industries will pay $450 to settle the Department of Justice's investigation into allegations of price fixing and misuse of funds for kickbacks. Other pharmaceutical news reports ...

Only 40% of Medicare Advantage health prescription drug plans achieved a four-star rating or higher under the current criteria used by Centers for Medicare and Medicaid Services to grade quality. The ...